As-Needed Use of Short-Acting β2-Agonists Alone Versus As-Needed Use of Short-Acting β2-Agonists Plus Inhaled Corticosteroids in Pediatric Patients With Mild Intermittent (Step 1) Asthma: A Cost-Effectiveness Analysis

Autor: Rodríguez-Martínez, Carlos E., Sossa-Briceño, Monica P., Buendia, Jefferson Antonio
Zdroj: In The Journal of Allergy and Clinical Immunology: In Practice June 2022 10(6):1562-1568
Databáze: ScienceDirect